📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin. (2022)

First Author: Dowey R
Attributed to:  Optimising Innate Host Defence to Combat Antimicrobial Resistance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00596-2021

PubMed Identifier: 35382002

Publication URI: http://europepmc.org/abstract/MED/35382002

Type: Journal Article/Review

Volume: 8

Parent Publication: ERJ open research

Issue: 2

ISSN: 2312-0541